In a new study, Canadian scientists discovered that a molecule called D-lactate, produced by gut bacteria, contributes to high blood sugar and fatty liver disease in obese mice and humans. This microbial-produced fuel enters the bloodstream and signals the liver to create excess glucose and fat, acting as a previously unknown branch of the classic Cori cycle. To combat this, the researchers developed a novel "gut substrate trap," a safe, oral polymer that binds to D-lactate in the intestines, preventing its absorption. When given to obese mice, this trap significantly improved blood sugar control, reduced insulin resistance, and lessened liver inflammation and damage, all without altering diet or body weight, opening a potential new avenue for treating metabolic diseases.
Microplastics at everyday doses caused insulin resistance and liver damage in mice
A news item on a study linking dietary microplastics to early liver damage, gut disruption and glucose problems in mice. Gokhan's own view that microplastics are the new smoking is opinion; the study itself is animal data.



